Our previous work showed that the active site heterogeneity in heavy meromyosin (HMM) becomes evident when highly reactive SH-groups in HMM are modified by thimerosal (Kawamura, Higuchi, Emoto, & Tawada (1985 ) /. Biochem. 97, 1583-1593. The heterogeneity was revealed by "affinity-labeling" analysis with vanadate plus ADP, which was developed in the previous paper. To see whether this heterogeneity is due to the head-head interaction or two different alkali light chains present in HMM, we carried out similar studies with myosin subfragment-1 (SI) and one of the isozymes, S1(A1), which contains only the alkali light chain 1, and obtained essentially the same results as those previously obtained with HMM. The SI results are easily explained by the same hypothesis previously used for explaining the HMM results: SH-modified SI or S1(A1) contains two kinds of active site in a 1 : 1 ratio with almost the same ATPase activity: one hydrolyzes ATP by a mechanism giving a protein Trp fluorescence enhancement, whereas the other hydrolyzes ATP by another mechanism giving no fluorescence enhancement.
this view, one pathway occurring at one of the two active sites of a myosin molecule involves the same rate-limiting intermediate, M**ADPPi, as given above, but the other pathway occurring at the other site of the molecule involves MATP as a rate-limiting intermediate without enhancement of protein fluorescence. In other words, the first view (referred to as the single-pathway mechanism) assumes a single kind of active site for myosin ATPase, whereas the second view (referred to as the two-pathway mechanism) assumes two kinds of active site for the ATPase.
In our previous work, we described a simple method for discriminating the single-pathway mechanism from the other mechanism for myosin ATPase (9) . This method uses vanadate (Vi) plus ADP as a reversible "affinity label" (10) (11) (12) . Application of the method revealed that the active site heterogeneity in heavy meromyosin (HMM) becomes evident when reactive sulfhydryl (SH)-groups in the protein are pre-modified by thimerosal (9) .
This heterogeneity in HMM could be due to its head-head interaction or to two different alkali light chains present in HMM (13) . To check these possibilities, we have carried out similar studies with myosin subfragment-ls: S1(A1/A2 mixture) and S1(A1) in the present study. In this work, we have also attempted to find better conditions for SH-modification which would make the active site heterogeneity more prominent.
In this paper, we will show the following: (1) the results obtained by applying the above method to SH-modified SI are almost the same as those previously obtained with SH-modified HMM (9); (2) these results obtained with SI are easily explained, as were the previous HMM results, by the hypothesis that SH-modified myosin (SI) contains two kinds of active site with almost the same ATPase activity in a 1 :1 ratio : one hydrolyzes ATP, giving a protein fluorescence enhancement, and the other hydrolyzes ATP, giving no fluorescence enhancement.
MATERIALS AND METHODS

Reagents Used and Preparation of Proteins-
ATP and thimerosal were purchased from Sigma Co. "V^Oj was purchased from Nakarai Chemical Co., Kyoto, Japan, and a-chymotrypsin was purchased from Millipore Corp., Bedford, MA, U.S.A. Myosin was prepared from rabbit skeletal muscle by the method of Perry (14) . SI was prepared by chymotryptic digestion of myosin by the method of Weeds and Taylor (IS) and purified by ammonium sulfate fractionation. S1(A1) was separated from S1(A2) by chromatography on DEAE-Sepharose CL-6B (Pharmacia Fine Chemicals, Pharmacia Japan, Tokyo) equilibrated with buffer 1 (see Table I for the composition of buffers). The purity of preparations was checked by sodium dodecyl sulfate polyacrylamide gel electrophoresis (16) . The molecular weight of SI was taken as 120,000. Protein concentration of SI (mg/ml) was calculated based on an absorbance coefficient of 0.75 cm-1 at 280 nm (17). Vi solution: Stock solutions of Vi were prepared, and the concentration of Vi was determined, as described by Goodno (10) . SI (1 nig/ml protein) was allowed to react with thimerosal for 2 h at 4°C in bufTer 4 (for Figs. 1, 2, and 3) or in buffer 8 (for Figs. 4, 5, and 6). The modification reaction was terminated by removing free thimerosal by extensive dialysis against 100 X volume of dialysis buffers using 16 mm diameter dialysis tubes (Visking Cellulose Tubing #16/32, Union Carbide Corp., New York) at 4°C. The dialysis was carried out against buffer 2 (three changes: 1 h+2h+overnight) for Figs. 1, 2, and 3; or buffer 7 (4 h+ overnight + overnight) followed by buffer 5 (overnight) and buffer 2 (overnight) for Figs. 4, 5, and 6. When the SH-groups were titrated, the last dialysis buffer was replaced with buffer 6.
Modification of SH-Groups with Thimerosal-
SH-content:
The content of SH-groups was determined by the method of Ellman (18) , as previously described (?).
ATPase activity: ATPase activity of SI was determined by measuring the time course (more than 4 different time points) of Pi liberation at 25°C. The reaction mixture contained ATP (1 or 5 ITIM) and SI in buffer 3. The concentration of SI was between 0.05 and 0.85 mg/ml. Pi was determined by the method of Taussky and Shorr (19) after stopping the ATPase reaction with 10% trichloroacetic acid.
Fluorescence measurements: Fluorescence measurements were carried out using a Hitachi 650-10M spectrofluorometer at 25 C C. The excitation wavelength was 295 run and the fluorescence emission wavelength was 335 nm. Six /A of 50 mM ATP was added to 2 ml of SI (0.1 mg/ml) in buffer 3, and the fluorescence enhancement was measured. Two or three measurements were repeated with each preparation and the average was taken.
The MADPVi complex: The complex was isolated by gel-filtration according to the method of Goodno (10) with slight modification as follows. SI (1 mg/ml) was mixed with 2 mM Vi and 5 mM ATP in buffer 3, followed by incubation at 25°C for 90min. The mixture (less than 5 ml) was applied to a column of Sephadex G-25 Fine (2.7 x 14 cm) equilibrated with buffer 3, and the protein was eluted at a flow rate of less than 1 ml/min at 4°C.
The amount of Vi sequestered by the MADPVi complex was determined, as previously described Regression analysis: Regression analysis was applied to the determination of the SH-group content, the amount of the sequestered Vi and the ATPase activity (9) . The regression analysis together with the calculation of the propagation of error gave the estimated standard error (referred to as S.E.) for each value (20) .
RESULTS
First, we describe an outline of the method, which we used previously (9) to discriminate the singlepathway mechanism from the two-pathway mechanism of myosin ATPase, as described in the introduction.
Outline of Analysis Method-Vi together with ADP stoichiometrically binds to the active site of myosin and forms an inactive stable MADPVi complex, thereby inhibiting the activity (10) . Addition of ATP does not enhance the protein fluorescence of the MADPVi complex (70). Therefore, if the fraction of myosin labeled by Vi plus ADP is varied, both the ATPase activity and the amplitude of the protein fluorescence enhancement induced by ATP will change correspondingly. If myosin consists of only one kind of active site generating a rate-limiting M**ADPPi complex as assumed in the single-pathway mechanism, the relative change in the ATPase activity should be proportional to that in the amplitude of the ATPinduced fluorescence enhancement, when the labeled fraction of myosin is varied. Thus, if these two changes are not proportional to each other, this means that the single-pathway mechanism is wrong. To explain the non-proportionality, one would have to assume the existence of heterogeneous active sites for myosin ATPase. On the other hand, if these two changes are proportional to each other, this does not necessarily mean that the single-pathway mechanism is correct. This is because these two changes can be proportional to each other under certain conditions even when the two-pathway mechanism is assumed.
As previously described (9) , when the analysis method was applied to native (unmodified) HMM, these two changes were not proportional to each other, but the deviation from the proportionality was very small. Applying the analysis method to native SI, we again found that these two changes were almost proportional to each other (data not Vol. 98, No. 3, 1985 shown).
However, the deviation from the proportionality in these two changes was very large with HMM in which 5 (per head) highly reactive SHgroups were pre-modified with thimerosal, as previously described (9) . These results indicating the heterogeneity in the active site were easily explained by assuming two different kinds of active site present in a 1 : 1 ratio (9) . Following this work, we have first examined SH-modification of SI by thimerosal to find conditions where highly reactive SH-groups of SI are completely modified. In part I, we describe the results of the SH-modification and those obtained by applying the analysis method to SH-modified SI; in part II, we will describe other results obtained with SI in which SH-groups were pre-modified under different conditions. In most cases, each experiment was repeated both with S1(A1) and S1(A1/A2 mixture). However, because the results obtained with the Al isozyme and those with S1(A1/A2 mixture) were almost the same, we will only describe those with S1(A1).
Part I-Modification of S1(A1) by thimerosal: Figure 1 shows the modification of S1(A1) SHgroups by thimerosal, and its effects on both the ATPase activity and the ATP-induced fluorescence enhancement.
Four SH-groups per S1(A1) were relatively highly reactive to thimerosal. Modification of the most reactive of these 4 SH-groups was associated with 6-fold activation of the ATPase activity. At the maximum level of modification of the 4 SHgroups, the fluorescence enhancement induced by ATP was reduced to about 45% of that before the SH-modification. These results are similar to Fig. 1. Effects of S1(A1) SH-modification by thimerosal on both the ATPase activity and the amplitude of the fluorescence enhancement induced by ATP. o, ATPase activity relative to that of unmodified S1(A1); A, amplitude of the fluorescence enhancement induced by ATP relative to that of unmodified S1(A1); D, the number of modified SHgroups (M/M), determined as the difference of SH-groups between unmodified and SHmodified S1(A1) preparations. Each value is plotted as a function of added thimerosal (M/M of S1(A1)). Measurements of SH-numbers were repeated («=2 to 6 different preparations). The standard deviations of the SH measurements were between 0.3 and 1.7. The number of SH-groups in unmodified S1(A1) was 9.9±1.1 (M/M) (S.D., n=6 different preparations). The standard deviations for the amplitude of the fluorescence enhancement were less than 0.1 on the ordinate scale (n=2 to 4 different preparations). The estimated standard errors (S.E., see "MATERIALS AND METHODS") for the ATPase measurements were less than the size of the symbol. The steady-state ATPase activity of unmodified S1(A1) was 0.07±0.01 s" 1 (S.D., n=l different preparations). The amplitude of fluorescence enhancement induced by ATP of unmodified S1(A1) was 30.0± 2.1% (S.D., ra=8 different preparations). The intensity of the intrinsic Trp fluorescence of S1(A1) was reduced to about 83% of the original intensity when S1(A1) was modified with 2-fold or more molar excess of thimerosal over active sites.
/. Biochem. those obtained with HMM except for the number of highly reactive SH-groups (9) .
Thus, the results in Fig. 1 give the optimum conditions under which the highly reactive 4 SHgroups were completely modified. Hence, in the following experiments, the molar ratio of thimerosal added for the modification was fixed at 14, with respect to the active site.
Inhibition by vanadate ion of the SH-modified S1(A1) ATPase activity: The ATPase activity of SH-modified S1(A1) was inhibited by Vi in the presence of MgATP (Fig. 2) , as was found with native and SH-modified HMM (9, 10) . The inhibition is due to generation of the inactive MADPVi complex at the active site (9, 10) . At 2 mM Vi (filled circles in Fig. 2 ), a relatively rapid initial inhibition was followed by a slower progressive inhibition. The first-order plot (not shown) showed that the activity was reduced to less than 10% over a period of 90 min.
Although the ternary complex of native HMM with Vi plus ADP is very stable {10), the ternary complex of SH-modified HMM was less stable (9) . Because preliminary experiments showed that this is also so with SH-modified S1(A1), we analyzed the reactivation process rather than inactivation process with SH-modified S1(A1).
Kinetics of reactivation of SH-modified S1(A1) inactivated by Vi plus ADP:
In the present ex- periments, SH-modified S1(A1) was first subjected to inhibition by 2 mM Vi in MgATP at 25°C for 90 min, and then isolated by gel filtration. The kinetics of reactivation of S1(A1) after gel filtration was studied by following the recovery of the ATPase activity and that of the ATP-induced fluorescence enhancement. A typical example of the reactivation kinetics is shown in Fig. 3a . Data at time zero could not be obtained because the ATPase activity and fluorescence measurements were carried out with protein samples after gel filtration. (The gel filtration took about 0.5 h.) However, because the relative ATPase activity of S1(A1) just before the application to the gel column was less than 0.1, as described above, and the relative ATPase activity at 1 h in Fig. 3a was 0.35, the relative ATPase activity at time zero in Fig. 3a was estimated to be less than 0.25.
The recovery of the ATPase activity was not correlated with that of the ATP-induced fluorescence enhancement. The finding that these two recovery processes are not proportional to each other (Fig. 3b) can not be explained by the singlepathway mechanism of myosin ATPase. Instead, it implies the existence of heterogeneous active sites in the SH-modified S1(A1), as pointed out in Outline of Analysis Method given above.
To obtain more information about the heterogeneity, parallel experiments were carried out to follow changes in the amount of Vi sequestered by S1(A1) after the gel filtration (filled circles in Fig. 3a) . The time course of (1 -bound Vi/active site) was well correlated with the recovery of the ATPase activity. The good correlation indicates that the degradation of the inactive MADPVi complex accompanies the concomitant recovery of the ATPase activity. On the other hand, the recovery of the ATP-induced fluorescence enhancement did not correlate with the time course of (1 -bound Vi/active site).
As described previously (9), it was not possible to examine 100% recovery of the fluorescence enhancement, because partial denaturation of SHmodified HMM or SI took place, on storage for a long time, such as 8 days, before 100% recovery was attained. (See " DISCUSSION" for a theoretical explanation of this slow recovery phase.)
The results shown in cept that a lag in the fluorescence recovery was present with SH-modified HMM but not with SH-modified SI. The results in Fig. 3 can be explained by assuming that SH-modified S1(A1) contains two different kinds of active site in a 1 :1 ratio: one splitting ATP, giving fluorescence enhancement, and the other doing so without giving fluorescence enhancement, as will be fully discussed later. This assumption together with an additional one of co-operative interaction between the two heads in the HMM molecule can explain the lag phase in the fluorescence recovery of HMM (see " AP-PENDIX").
The calculation based on these assumptions, given in "DISCUSSION," shows that the rate of release of Viplus ADP from one kind of active site is only 5 times greater than that from the other kind of site. If the difference were greater, the presence of "two" different kinds of active site would be more prominent in an analysis such as that shown in Fig. 3 . Therefore, we attempted to find other conditions of SH-group modification by thimerosal, which would give a clearer result. By trial and error, we found that modification in the presence of MgPPi is suitable.
Part II-Modification ofSl(Al) by thimerosal in the presence of MgPP\:
The experimental procedures in this case were similar to those for Fig.  1 . Figure 4 shows that 5 SH-groups are highly reactive to thimerosal in the presence of MgPPi. Modification of the most reactive 1 or 2 SH-groups in these 5 SH-groups was associated with the activation of the ATPase activity, two-fold activation in this figure in contrast to the six-fold activation in Fig. 1 . At the maximum level of modification of the 5 SH-groups, the amplitude of the ATP-induced fluorescence enhancement was reduced to 35% of that before the modification.
Since the reactive 5 SH-groups are almost completely modified when the modification is carried out at a thimerosal-to-site ratio of above 60 (up to 130), S1(A1) was modified in the presence of MgPPi by thimerosal at the reagent-to-site ratio of 65 for the following experiments. SI thus modified will be referred to as the 2nd-type SHmodified SI.
Inhibition by Vi and reactivation of the 2nd-type SH-modified S1(A1):
The ATPase activity of the 2nd-type SH-modified S1(A1) was more quickly inhibited by Vi than that of the lst-type SH-modified S1(A1) (Figs. 5 and 2) . The activity at 2 mM Vi (filled circles in Fig. 5 ) was reduced to less than 5 % over a period of 90 min. Figure 6 shows the reactivation experiments with the 2nd-type SH-modified S1(A1). The experimental procedures are the same as in Fig. 3 . In Fig. 6a , the ATPase activity recovered more quickly but the fluorescence enhancement recovered more slowly, than in Fig. 3a . The recovery of the ATPase activity was again correlated with the release of bound Vi from the active site (Fig.  6a) . At 3 h after the end of gel filtration, about 50% of the active site had formed the inactive MADPVi complex. At this time point, the ATPase activity had recovered to about 50% but the fluorescence enhancement had recovered relatively little. These findings indicate heterogeneity in the active sites of the 2nd-type SH-modified S1(A1). The results shown in Fig. 6 can be well explained by the same model as used for the explanation of the results shown in Fig. 3 (see " DISCUSSION" almost the same ATPase activity exist in a 1 : 1 ratio in SH-modified S1(A1).
2) One type of active site (referred to as the F-site) splits ATP, giving an ATP-induced enhancement of the protein fluorescence, whereas the other type of active site (referred to as the NF-site) splits ATP without giving a fluorescence enhancement.
3) Both types of active site generate the inactive MADPVi complex in the presence of Vi and ATP. However, the rate of degradation of the MADPVi complex generated at the NF-site is greater than that of the MADPVi complex generated at the F-site when the MADPVi complexes have been isolated by gel filtration.
4) A fraction of the MADPVi complex generated at the F-site irreversibly changes into a dead-end stable complex.
The first assumption explains the good correlation between the degradation of the MADPVi complex and the recovery of the ATPase activity (Figs. 3a and 6a) . The 2nd and 3rd assumptions explain the almost complete inhibition of the ATPase activity by Vi in MgATP (Figs. 2 and 5) , and the difference between the recovery of the ATPase activity and that of the ATP-induced fluorescence enhancement (Figs. 3 and 6 ). These three assumptions were previously used for the explanation of the results obtained with SH-modified HMM (9) . The 4th assumption explains the slower recovery in the latter half phases in Fig.  3a (from 20 to 54 h) and in Fig. 6a (from 10 to 50 h).
Since most of the discussion given in our previous paper (9) is applicable to the case of S1(A1), we will not repeat the details here. Instead, we will mainly focus on the quantitative explanation of the results in terms of the above assumptions. Figure 7 illustrates a model which is consistent with the above four specific assumptions. From the model, we can derive simple mathematical expressions for the recovery of the ATPase activity and that of the ATP-induced fluorescence enhancement. The relative value of the fluorescence enhancement recovery may be written as, for Fig. 6 ; a = 0.55 and /3=0.45 in both Figs. 3 and 6. All the active sites were assumed to trap Vi plus ADP at t=0 in deriving these equations for the sake of simplicity. The time zero for the calculation was put at -0.5 h on the abscissa and is shown by the dashed line in Figs. 3a and 6a . This zero-time was estimated by considering the time required for gel filtration on G-25. These equations fit the data well. Note that the ratio of the two degradation rate constants (k a /k { ) is 5 for Fig. 3 whereas it is 33 for Fig. 6 . The difference means that degradation of the MADPVi complex at the NF-site relative to that at the F-site is more rapid in Fig. 6 than in Fig. 3 : bound Vi plus ADP is released mainly from the NF-site in the early phases during the recovery in Fig. 6 .
AF.l. (K\.) = k t (l-e-
The model shown in Fig. 7 predicts that a fraction of the F-site (=kj(/ct + k t )) keeps forming the MADPVi complex as a dead-end complex even at /=oo; 100% recovery in both the ATPase activity and the fluorescence enhancement can not be attained if Ari^O. In fact, the curve-fitting of the theoretical recovery equations in both Figs. 3 and 6 required that Ari^O. Hence, experimental 100% recovery in Figs. 3a and 6a may not be attained because of this dead-end complex formation even if the proteins were stable enough for long-term experiments. The mechanism of the dead-end complex formation is not clear. The dead-end complex appears to have been formed in the recovery process of SH-modified HMM, as will be analyzed in " APPENDDC."
Possible Explanation for the Existence of the Heterogeneity in the Active Sites of the SH-Modified S1(A1)-As pointed out previously (9), two explanations are possible for the existence of the heterogeneous active sites in SH-modified S1(A1). The first is that some sort of (probably 1 : 1) heterogeneity pre-exists in the microenvironment of the active sites and that the SH-modification enhanced the heterogeneity. The second is that no heterogeneity pre-exists in the active site but that the SH-modification introduced the heterogeneity. As pointed out in our previous paper (9), the second explanation can not be ruled out completely at present. However, as also pointed out previously (9) , it is unlikely that the almost complete modification of the highly reactive SHgroups introduced a new (and as large as 1 : 1) heterogeneity in the active site. The unlikeliness of the second explanation is further indicated by the finding that SI modified under two different conditions (i.e., in the absence and the presence of MgPPO gave similar results and these results could be quantitatively explained by a single model, as shown in Figs. 3 and 6 . Thus, the first explanation appears to be more likely. This in turn suggests that there are (at least two) different heavy chains in S1(A1) and that the active site heterogeneity is due to their difference.
Tong and Elzinga (21) suggested the presence of two different heavy chains in rabbit skeletal myosin, based on structural (amino acid sequence) microheterogeneity in the 23 kDa fragment of SI, and estimated a ratio of 6 : 4 between them. The ratio is rather close to our value suggested for Vol. 98, No. 3, 1985 the heterogeneity in the active sites of the SHmodified S1(A1).
The selective labeling of the F-site by Vi plus ADP, which was developed in the present study, would be suitable for separating S1(A1) having the F-site from S1(A1) having the NF-site by the use of an ADP-column. This separation would make it possible to check whether the active site heterogeneity really corresponds to heterogeneity in the amino acid sequence (27), and would further elucidate other characteristics of the difference between the different Sl(Al)s.
APPENDIX
Recovery Process of SH-Modified HMM Labeled by Vi Plus ADP-There was a lag phase in the fluorescence recovery of HMM (9) , whereas the lag phase was absent in that of S1(A1) (Figs. 3a and 6a). The lag phase can be explained by assuming co-operative interaction between the two heads of an HMM molecule in addition to the four assumptions given in " DISCUSSION." The co-operativity assumption is:
One HMM molecule contains two different active sites: the F-site on one of the two heads and the NF-site on the other head. The MADPVi complex generated at the F-ske in an HMM molecule degrades only after the degradation of the complex generated at the NF-site in the same HMM molecule. The definitions of the parameters are the same as those given in Fig. 7 . All the active sites were assumed to trap Vi plus ADP at t=0 in deriving these equations for the sake of simplicity. These theoretical recovery equations were fitted to the experimental data for SH-modified HMM which were taken from Ref. /. Biochenu
